309 related articles for article (PubMed ID: 24097976)
21. Protease-Activated Receptor 4 Variant p.Tyr157Cys Reduces Platelet Functional Responses and Alters Receptor Trafficking.
Norman JE; Cunningham MR; Jones ML; Walker ME; Westbury SK; Sessions RB; Mundell SJ; Mumford AD
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):952-60. PubMed ID: 26966273
[TBL] [Abstract][Full Text] [Related]
22. Molecular mapping of thrombin-receptor interactions.
Ayala YM; Cantwell AM; Rose T; Bush LA; Arosio D; Di Cera E
Proteins; 2001 Nov; 45(2):107-16. PubMed ID: 11562940
[TBL] [Abstract][Full Text] [Related]
23. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
24. Systems biology insights into the meaning of the platelet's dual-receptor thrombin signaling.
Sveshnikova AN; Balatskiy AV; Demianova AS; Shepelyuk TO; Shakhidzhanov SS; Balatskaya MN; Pichugin AV; Ataullakhanov FI; Panteleev MA
J Thromb Haemost; 2016 Oct; 14(10):2045-2057. PubMed ID: 27513817
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR
J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340
[TBL] [Abstract][Full Text] [Related]
27. Thrombin-induced reactive oxygen species generation in platelets: A novel role for protease-activated receptor 4 and GPIbα.
Carrim N; Arthur JF; Hamilton JR; Gardiner EE; Andrews RK; Moran N; Berndt MC; Metharom P
Redox Biol; 2015 Dec; 6():640-647. PubMed ID: 26569550
[TBL] [Abstract][Full Text] [Related]
28. PAR1-stimulated platelet releasate promotes angiogenic activities of endothelial progenitor cells more potently than PAR4-stimulated platelet releasate.
Huang Z; Miao X; Luan Y; Zhu L; Kong F; Lu Q; Pernow J; Nilsson G; Li N
J Thromb Haemost; 2015 Mar; 13(3):465-76. PubMed ID: 25495701
[TBL] [Abstract][Full Text] [Related]
29. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets.
Covic L; Gresser AL; Kuliopulos A
Biochemistry; 2000 May; 39(18):5458-67. PubMed ID: 10820018
[TBL] [Abstract][Full Text] [Related]
30. PKC inhibition markedly enhances Ca2+ signaling and phosphatidylserine exposure downstream of protease-activated receptor-1 but not protease-activated receptor-4 in human platelets.
Harper MT; Poole AW
J Thromb Haemost; 2011 Aug; 9(8):1599-607. PubMed ID: 21649850
[TBL] [Abstract][Full Text] [Related]
31. Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones.
Vellani V; Kinsey AM; Prandini M; Hechtfischer SC; Reeh P; Magherini PC; Giacomoni C; McNaughton PA
Mol Pain; 2010 Sep; 6():61. PubMed ID: 20875131
[TBL] [Abstract][Full Text] [Related]
32. Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.
Chen WF; Lee JJ; Chang CC; Lin KH; Wang SH; Sheu JR
Haematologica; 2013 May; 98(5):793-801. PubMed ID: 23065519
[TBL] [Abstract][Full Text] [Related]
33. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
[TBL] [Abstract][Full Text] [Related]
34. Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.
Duvernay M; Young S; Gailani D; Schoenecker J; Hamm HE
Mol Pharmacol; 2013 Apr; 83(4):781-92. PubMed ID: 23307185
[TBL] [Abstract][Full Text] [Related]
35. Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP.
Adam F; Verbeuren TJ; Fauchère JL; Guillin MC; Jandrot-Perrus M
J Thromb Haemost; 2003 Apr; 1(4):798-804. PubMed ID: 12871418
[TBL] [Abstract][Full Text] [Related]
36. Macrophage Migration Inhibitory Factor Mediates PAR-Induced Bladder Pain.
Kouzoukas DE; Meyer-Siegler KL; Ma F; Westlund KN; Hunt DE; Vera PL
PLoS One; 2015; 10(5):e0127628. PubMed ID: 26020638
[TBL] [Abstract][Full Text] [Related]
37. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
Judge HM; Jennings LK; Moliterno DJ; Hord E; Ecob R; Tricoci P; Rorick T; Kotha J; Storey RF
Platelets; 2015; 26(3):236-42. PubMed ID: 24750101
[TBL] [Abstract][Full Text] [Related]
38. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.
Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP
Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217
[TBL] [Abstract][Full Text] [Related]
39. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets.
Ma L; Perini R; McKnight W; Dicay M; Klein A; Hollenberg MD; Wallace JL
Proc Natl Acad Sci U S A; 2005 Jan; 102(1):216-20. PubMed ID: 15615851
[TBL] [Abstract][Full Text] [Related]
40. Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets.
Arachiche A; de la Fuente M; Nieman MT
PLoS One; 2013; 8(2):e55740. PubMed ID: 23405206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
